Monthly Newsletter from the Arizona Asthma Coalition |
|
|
Save Your Seat for the 18th Annual Arizona Asthma & Allergy Clinical Conference!
September 21, 2024 ·8 am - 2 pm · Creighton University, Phoenix |
|
|
Join us for the 18th Annual Wheezing & Sneezing in the Desert Conference on September 21, 2024. Featured speakers will address topics ranging from new treatments for asthma, allergy, and atopic dermatitis, to improving indoor air quality to healthcare/ school collaborative care. This event promises a comprehensive educational experience designed for pediatric and adult primary care providers, asthma specialists, nurse practitioners, physician assistants, pharmacists, respiratory therapists, nurses, school nurses, and other healthcare professionals. Discover new insights, network with peers, and earn CMEs and CEUs. Don't miss out on this opportunity to enhance your clinical care and improve patient outcomes! |
|
|
|
|
|
|
Some drugmakers to cap cost of asthma inhalers at $35 a month
NBC News
Starting [this month], the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim. Following years of public outcry about the high cost of inhalers, the two drugmakers — along with a third, GlaxoSmithKline — have committed to capping the out-of-pocket cost at $35 a month. GSK’s cap is expected to take effect by Jan. 1. |
|
|
|
|
GSK’s asthma drug shows promise in reducing severe attacks
WSAU/Reuters
GSK’s asthma drug met its primary goal of reducing asthma attacks over a 52-week period in a late-stage trial, the British drugmaker said on Tuesday. The drug, called Depemokimab, has the potential to be the first approved ultra-long-acting biologic with a six-month dosing schedule for patients with severe asthma, GSK said in a statement.
|
|
|
|
|
How are asthma and heart health linked?
American Heart Association
Although the heart and lungs are neighbors in your chest, people may think of them as separate entities with unrelated problems. But a growing body of evidence suggests that asthma – one of the most common lung disorders – is a risk factor for cardiovascular disease. Asthma is a serious chronic disease in which airways are inflamed, often in response to specific triggers. It affects about 25 million people in the U.S., including nearly 5 million children, causing millions of annual visits to doctors' offices and emergency rooms. |
|
|
|
|
Study Finds SMART Combination Inhaler Regimen For Asthma Treatment Is Under Prescribed
Pharmacy Times
According to study findings, approximately 14.5% of adult patients who have moderate to severe asthma are prescribed the recommended Single Maintenance and Reliever Therapy (SMART) combination inhaler regimen. The data were presented that the 2024 American Thoracic Society International Conference in San Diego, which was held May 17 to May 22.
|
|
|
|
|
Extreme Heat Associated With Children’s Asthma Hospital Visits
American Thoracic Society
For children seeking care at a California urban pediatric health center, extreme heat events were associated with increased asthma hospital visits, according to research published at the ATS 2024 International Conference. |
|
|
|
|
Multiple air pollutants linked to asthma symptoms in children
Washington State University
Exposure to several combinations of toxic atmospheric pollutants may be triggering asthma symptoms among children, a recent analysis suggests. The study, published in the journal Science of the Total Environment, showed that 25 different combinations of air pollutants were associated with asthma symptoms among 269 elementary school children diagnosed with asthma in Spokane, Washington. In line with previous research, the Washington State University-led study revealed a socioeconomic disparity — with one group of children from a lower-income neighborhood exposed to more toxic combinations, a total of 13 of the 25 identified in this research. |
|
|
|
|
Join the Arizona Asthma Coalition As a nonprofit partnership since 1996, AAC has worked together with concerned stakeholders including public health, environmental quality, managed care, education, individual physicians and nurses, hospitals, foundations, families and other colleagues. Become a member of the Arizona Asthma Coalition or renew your membership and help us continue this important work. Join or renew here |
|
|
|
